The chemical class known as γA-crystallin, also known as CRYGA, inhibitors is made up of various agents that are known to interact with and alter the structural proteins of the eye lens, particularly γA-crystallin. These inhibitors are not selective in the traditional sense of target interactions but instead impact γA-crystallin through a range of non-specific interactions that can lead to protein destabilization, misfolding, or aggregation. The consequences of these interactions are significant, as γA-crystallin is crucial for maintaining the transparency and refractive index of the lens. Agents that interact with γA-crystallin can induce oxidative stress or modify amino acid residues, which in turn disrupt the delicate arrangement of proteins that is necessary for lens clarity. Other such agents can act as chaotropic agents that interfere with the hydrophobic core of γA-crystallin, leading to a loss of its native structure and promoting protein aggregation.
The mechanisms by which these chemicals interact with γA-crystallin are diverse. Some are known to form covalent modifications with specific amino acid residues, altering the protein's structure and solubility, while others may displace essential metal ions from metalloproteins, thereby altering protein conformation and stability. Additionally, the redox state within the lens environment can be perturbed by certain chemicals, which can indirectly impact γA-crystallin by disrupting the balance of reducing and oxidizing agents. The consequence of such interactions is frequently an increase in protein aggregation, which can result in lens opacity. Importantly, these interactions are not exclusive to γA-crystallin and often reflect a broader impact on the proteome of the lens. However, due to the critical role of γA-crystallin in maintaining lens transparency, its alteration by these agents is particularly noteworthy. The agents that interact with γA-crystallin demonstrate the protein's vulnerability to environmental and chemical stresses, which underscores the importance of understanding protein chemistry to safeguard the structural integrity of lens proteins.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $30.00 $60.00 $93.00 | 27 | |
Causes oxidative modification of amino acids in CRYGA, leading to protein misfolding, aggregation, and lens opacity. | ||||||
Methylglyoxal solution | 78-98-8 | sc-250394 sc-250394A sc-250394B sc-250394C sc-250394D | 25 ml 100 ml 250 ml 500 ml 1 L | $143.00 $428.00 $469.00 $739.00 $1418.00 | 3 | |
Reacts with arginine, lysine, and cysteine residues in CRYGA, forming AGEs that could inhibit CRYGA through aggregation. | ||||||
Urea | 57-13-6 | sc-29114 sc-29114A sc-29114B | 1 kg 2 kg 5 kg | $30.00 $42.00 $76.00 | 17 | |
At high concentrations, can disrupt hydrogen bonding and hydrophobic interactions in CRYGA, which could inhibit CRYGA by causing denaturation and potential aggregation. | ||||||
Guanidine Hydrochloride | 50-01-1 | sc-202637 sc-202637A | 100 g 1 kg | $60.00 $195.00 | 1 | |
Acts as a chaotropic agent, unfolding CRYGA and increasing the risk of protein aggregation, which could inhibit CRYGA. | ||||||
Sodium iodate | 7681-55-2 | sc-251029 sc-251029A | 100 g 500 g | $46.00 $185.00 | 1 | |
Induces oxidative damage in lens proteins like CRYGA, which could inhibit CRYGA by disrupting its structure and leading to cataract formation. | ||||||
Acrylamide Solution, 40% | 79-06-1 | sc-3721 | 1 L | $98.00 | ||
Can form adducts with lysine residues in CRYGA, potentially leading to altered protein conformation and aggregation, which could inhibit CRYGA. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $55.00 $179.00 $345.00 | 1 | |
Binds to proteins and can replace metal ions in metalloproteins, potentially changing the structure and function of CRYGA, which could inhibit its normal function. | ||||||
Paraquat chloride | 1910-42-5 | sc-257968 | 250 mg | $149.00 | 7 | |
Generates superoxide radicals, leading to oxidative stress and potential modification of CRYGA, which could inhibit its function. |